counter create hit Pharmaceutical Computer Systems Validation: Quality Assurance, Risk Management and Regulatory Compliance - Download Free eBook
Ads Banner
Hot Best Seller

Pharmaceutical Computer Systems Validation: Quality Assurance, Risk Management and Regulatory Compliance

Availability: Ready to download

Thoroughly revised to include the latest industry developments, the Second Edition presents a comprehensive overview of computer validation and verification principles and how to put them into practice. To provide the current best practice and guidance on identifying and implementing improvements for computer systems, the text extensively reviews regulations of pharmaceuti Thoroughly revised to include the latest industry developments, the Second Edition presents a comprehensive overview of computer validation and verification principles and how to put them into practice. To provide the current best practice and guidance on identifying and implementing improvements for computer systems, the text extensively reviews regulations of pharmaceuticals, healthcare products, blood processing, medical devices, clinical systems, and biotechnology. Ensuring that organizations transition smoothly to the new system, this guide explains how to implement the new GMP paradigm while maintaining continuity with current practices. In addition, all 24 case studies from the previous edition have been revised to reflect the new system. Key topics in Pharmaceutical Computer Systems Validation, Second Edition include: GAMP5, ASTM 2500, EU GMP (Annex 11), and US GMP revisions to regulatory requirements for electronic records and signatures that should be published in 2008 ICH Guidance Q8, Q9, and Q10 expectations FDA cGMPs for the 21st Century Initiative and associated guidance PIC/S Guidance on Good Practice for Computerized Systems in GxP Environments WK9864 Standard Guide for Specification, Design, and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment the indirect developments from FDA/EU/Japan regulators and industry the role of QA department, and internal and external suppliers the integration of computer systems validation into single overall approach for wider system practical guidance on handling common high, medium, and low risk issues that can occur during the life cycle of a computer system managing outsource partners and handling legacy systems topical issues uncovered by regulatory authorities including US FDA


Compare
Ads Banner

Thoroughly revised to include the latest industry developments, the Second Edition presents a comprehensive overview of computer validation and verification principles and how to put them into practice. To provide the current best practice and guidance on identifying and implementing improvements for computer systems, the text extensively reviews regulations of pharmaceuti Thoroughly revised to include the latest industry developments, the Second Edition presents a comprehensive overview of computer validation and verification principles and how to put them into practice. To provide the current best practice and guidance on identifying and implementing improvements for computer systems, the text extensively reviews regulations of pharmaceuticals, healthcare products, blood processing, medical devices, clinical systems, and biotechnology. Ensuring that organizations transition smoothly to the new system, this guide explains how to implement the new GMP paradigm while maintaining continuity with current practices. In addition, all 24 case studies from the previous edition have been revised to reflect the new system. Key topics in Pharmaceutical Computer Systems Validation, Second Edition include: GAMP5, ASTM 2500, EU GMP (Annex 11), and US GMP revisions to regulatory requirements for electronic records and signatures that should be published in 2008 ICH Guidance Q8, Q9, and Q10 expectations FDA cGMPs for the 21st Century Initiative and associated guidance PIC/S Guidance on Good Practice for Computerized Systems in GxP Environments WK9864 Standard Guide for Specification, Design, and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment the indirect developments from FDA/EU/Japan regulators and industry the role of QA department, and internal and external suppliers the integration of computer systems validation into single overall approach for wider system practical guidance on handling common high, medium, and low risk issues that can occur during the life cycle of a computer system managing outsource partners and handling legacy systems topical issues uncovered by regulatory authorities including US FDA

28 review for Pharmaceutical Computer Systems Validation: Quality Assurance, Risk Management and Regulatory Compliance

  1. 4 out of 5

    Kirill Kipke

  2. 5 out of 5

    Jose Ortiz

  3. 4 out of 5

    Sridhar Gaddipati

  4. 4 out of 5

    Lalithag

  5. 4 out of 5

    Georg Peilert

  6. 4 out of 5

    Shoaib Naqvi

  7. 5 out of 5

    Yagnasree

  8. 4 out of 5

    Jacob Silva

  9. 4 out of 5

    Andrew Boyd

  10. 4 out of 5

    Vivian G

  11. 4 out of 5

    Judeth

  12. 5 out of 5

    Aseem Rajbhandari

  13. 5 out of 5

    Anusha Gona

  14. 5 out of 5

    Abhishek Hp

  15. 5 out of 5

    K Robert

  16. 5 out of 5

    Avinash Kumar

  17. 4 out of 5

    Naimesh Patel

  18. 5 out of 5

    May Lam

  19. 5 out of 5

    Henry

  20. 4 out of 5

    NARAYAN BHATWADEKAR

  21. 5 out of 5

    Naveen Kumar

  22. 5 out of 5

    Sitaram Ventrapragada

  23. 5 out of 5

    Vinod

  24. 5 out of 5

    Sivakumar Mm

  25. 4 out of 5

    Deidre

  26. 5 out of 5

    Judith

  27. 4 out of 5

    Luan

  28. 5 out of 5

    Joe Garrido

Add a review

Your email address will not be published. Required fields are marked *

Loading...
We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy.